Table: Pharmarise Holdings - 6-MTH group results

Pharmarise Holdings

13/01/2022 08:30

Jan 13 (Reuters)- 
             Pharmarise Holdings Corp 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Nov 30, 2021        Nov 30, 2020     May 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               25.90               25.67            53.24    
                   (+0.9 pct)          (-0.4 pct)       (+1.7 pct)  
  Operating          788 mln             525 mln            1.50    
                   (+50.1 pct)         (+0.8 pct)       (+20.7 pct) 
  Recurring          814 mln             536 mln            1.44    
                   (+51.8 pct)         (+2.7 pct)       (+12.1 pct) 
  Net                250 mln             127 mln          438 mln   
                   (+96.5 pct)         (-78.6 pct)      (+2.8 pct)  
  EPS               26.94 yen           13.73 yen        47.19 yen  
  EPS Diluted       20.34 yen           11.87 yen                   
  Ann Div                               14.00 yen        14.00 yen  
  -Q2 div              NIL                 NIL                      
  -Q4 div                               14.00 yen        14.00 yen  
  
  NOTE - Pharmarise Holdings Corp. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T